作者
OA Cornely, Matteo Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, W Meersseman, M Akova, MC Arendrup, SEVTAP Arikan‐Akdagli, J Bille, E Castagnola, M Cuenca‐Estrella, J Peter Donnelly, AH Groll, R Herbrecht, WW Hope, HE Jensen, C Lass‐Flörl, G Petrikkos, MD Richardson, E Roilides, PE Verweij, C Viscoli, AJ Ullmann, ESCMID Fungal Infection Study Group (EFISG)
发表日期
2012/12
期刊
Clinical Microbiology and Infection
卷号
18
页码范围
19-37
出版商
Blackwell Publishing Ltd
简介
Clin Microbiol Infect 2012; 18 (Suppl. 7): 19–37
Abstract
This part of the EFISG guidelines focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations can be summarized in the abstract. Prophylactic usage of fluconazole is supported in patients with recent abdominal surgery and recurrent gastrointestinal perforations or anastomotic leakages. Candida isolation from respiratory secretions alone should never prompt treatment. For the targeted initial treatment of candidaemia, echinocandins are strongly recommended while liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength. Treatment duration for candidaemia should be a minimum of 14 days after the end of candidaemia, which can be determined by one blood culture per day until negativity. Switching to oral treatment after 10 days of intravenous therapy has been safe …
学术搜索中的文章
OA Cornely, M Bassetti, T Calandra, J Garbino… - Clinical Microbiology and Infection, 2012
OA Cornely, M Bassetti, T Calandra, J Garbino… - 2012